• Latest Posts

ErVaccine raises €4.5M to start therapeutic cancer vaccine trial

Ethris and DIOSynVax to develop mRNA betacoronavirus vaccine

Nykode Therapeutics and Richter-Helm BioLogics announce partnership

Providence Therapeutics’ mRNA rabies vaccine hits milestone

MinervaX raises €72M to develop Group B Streptococcus vaccine

Startup USSF bringing oral COVID vaccine to market

ADVERTISEMENT

The Native Antigen Company expands infectious disease portfolio

PDC*line Pharma presents first immunological results from trial with PDC*lung01

ExPLoRNA Therapeutics receives mRNA technology funding

Positive antibody persistence for vaccine treating mosquito disease

Trial for HPV16 positive oropharyngeal cancer completes enrolment for phase 2

Touchlight receives new grant to further develop doggybone DNA vaccine platform

ADVERTISEMENT